Current Status of Hormonal Therapy of Fibrocystic Breast Disease
- 1 June 1986
- journal article
- Published by Wiley in Annals of the New York Academy of Sciences
- Vol. 464 (1) , 350-363
- https://doi.org/10.1111/j.1749-6632.1986.tb16014.x
Abstract
No abstract availableThis publication has 36 references indexed in Scilit:
- Presence and characterization of prolactin receptors in human benign breast tumoursEuropean Journal of Cancer and Clinical Oncology, 1984
- Prognostic significance of serum prolactin levels in advanced breast cancerBritish Journal of Cancer, 1983
- PRL, TSH, and thyroid hormones in benign breast diseasesJournal of Molecular Medicine, 1981
- Production and processing of prolactinNature, 1981
- Circadian mesor-hyperprolactinemia in fibrocystic mastopathyThe American Journal of Medicine, 1979
- Treatment of benign breast disease with bromocriptineJournal of Endocrinological Investigation, 1979
- Serum prolactin concentrations in benign breast disease throughout the menstrual cyclePublished by Elsevier ,1977
- HYPERPROLACTINÆMIA AND LUTEAL INSUFFICIENCYThe Lancet, 1976
- Successful treatment of mastodynia with the prolactin inhibitor bromocryptine (CB 154)Archiv für Gynäkologie, 1975
- A possible role for prolactin in control of steroid secretion by the human Graafian follicleNature, 1974